Oncology Grants

American Society of Preventive Oncology/
Prevent Cancer Foundation

2009 Cancer Prevention Research Fellowship
For Young Scientists at the Postdoctoral or Clinical Fellow Level

2009 Research Fellowship in Cancer Prevention Research: This Fellowship, sponsored by the Prevent Cancer Foundation, will provide a two-year award of $40,000 per year to a young scientist in the U.S. or engaged in meritorious cancer prevention research or presenting a proposal deemed to have potential for advancing the general goals of cancer prevention.

Letter of Intent
Each applicant is required to submit a very brief letter of intent (via e-mail, fax)  by November 14, 2008.

Eligibility
Candidates must have completed the MD, PhD, or other doctoral degree. Candidates must currently be a postdoctoral or clinical research fellow and must have been a fellow for at least one year but not more than 4 years prior to the year of the award. Academic faculty holding the rank of assistant professor or higher, graduate or medical students, federal government employees and employees of private industry are not eligible. A candidate need not be a member of the American Society of Preventive Oncology (ASPO) at the time of application, but must be nominated by an ASPO member. Student members may not be nominators.

Selection Process
Applications will receive careful scientific evaluation by a multidisciplinary committee consisting of ASPO members who are experts in basic and clinical cancer prevention research. Applications must be received in complete form by December 3, 2008.

An application can be found at www.aspo.org

American Society of Hematology Research Training Award for Fellows

Goals of this program are:

To encourage and enable fellowship programs to provide time for research (clinical, basic science, or translational).
To promote mentorship of hematology trainees by outstanding faculty members.
To produce, on a yearly basis, clinician scientist candidates for academic track positions.
To provide bridging funds for trainees who need more time to generate sufficient expertise to be competitive when applying for K award funding.
Support

The ASH Research Training Award for Fellows will, on a three-year pilot basis, grant $50,000 for a one-year period to third- and fourth-year trainees (at time of the award) in training who are not yet eligible for the ASH Scholar Awards (fellow category).

This award is intended to be used primarily for salary support for the applicant. However, up to $5,000 may be allocated for research supplies and reagents, and up to $1,000 may be allocated for travel to the ASH annual meeting (no other meetings are eligible for this allocation). Each of the non-salary support portions of the budget must be accompanied by a clear justification.

Awards will be activated on July 1 and conclude on June 30 of the year following activation. Monies cannot be used toward salary/benefits for the mentor or toward an institution's overhead or indirect costs. Payments will be made to the appropriate financial officer of the institution.

Eligibility Criteria

The ASH Research Training Award for Fellows is intended for upper-level fellows who meet the following criteria.

At the time of application (January 5, 2009):

The applicant must either be an ASH Associate member or submit a membership application.

The applicant must not have any other career-development funding.

The applicant must have completed at least six months, but less then 18 months of post-doctoral research training.

The proposed research must be in hematology, hematology/oncology, or a hematology-related area.

The applicant should be planning to pursue an investigative career in hematology research.

The applicant must have clear and documented support of a funded mentor (funding may be NIH, federal, foundation, or private) and documented support from the program director for dedicated research time.

The applicant must have a mentor who is an ASH member. If the mentor is not an active ASH member, a letter of support from an ASH member must be included.

At least 75 percent of the applicant's full-time professional efforts must be devoted to research during the funded period.

No more then one awardee per fellowship program per year, and no more than one award per medical school per year. For this purpose, ASH defines medical school so that it encompasses all sub-institutions.
Requirements at the time of the award (July 1, 2009). The applicant must:

Be an MD, DO, DO/PhD, or MD/PhD

Have completed one year of clinical training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada

Be a third- or fourth-year trainee in a hematology, hematology/oncology, or hematology-related training program in the United States or Canada
The ASH Research Training Award for Fellows supports the same categories of research as the ASH Scholar Awards – basic research and clinical/translational research.

Letter-of-Intent Requirements

Applicants must submit a letter of intent by November 3, 2008, that includes the following:

A completed letter-of-intent form

Applicant's curriculum vitae to confirm eligibility

An abstract of proposed research study and a description if its relevance of the study to hematology
Application Requirements

Eligible candidates will be asked to complete an application which must include a:

Detailed description of the proposed research study,including information on the significance, originality, hypothesis, feasibility, and methodology

Letter confirming the availability of project specific institutional resources to support the proposed project

Co-authored, detailed career-development plan describing the applicant's current and future academic and research career plans, and the mentor's vision for mentor-applicant interaction

Letter of support from an ASH member (if the identified mentor is not an ASH member)

Biosketch for the mentor and the applicant including other support (active and pending); there is a four-page limit for each biosketch

Budget

Letter of support from the program director which must include statements:
indicating that a minimum of 75 percent of the recipient's time will be dedicated to research
defining the recipient's anticipated clinical responsibilities during the award period
describing the training program's financial need for this award
describing the salary support resources for all of the program's trainees (to include institutional funding, NIH training grants, etc.)
identifying the source(s) of the applicant's other salary support if he/she is a recipient of this award
Selection

The selection of award winners will be made by a study section appointed by members of the Award Study Section. Criteria for selection are:

The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to the potential for future independent investigation and commitment to a career in hematology research
Quality of the mentor and the plan for mentor/applicant interaction and career development
The significance, feasibility, and originality of the proposed hypothesis, research, and methodology
A focus on hematology research
Availability of institutional resources to support the proposed project
Ten finalists will be selected to be interviewed by the Award Study Section. All finalists for the award must be available for face-to-face interviews with the Study Section in March. The interviews will focus on determining the applicants' commitment to hematology and potential for success.

Timeline

Letter of intent due November 3, 2008
Application due January 5, 2009
Finalist interviews March 2009
Notification of awards April 2009
Activation of award July 1, 2009

American Society of Hematology
1900 M St., NW, Suite 200
Washington, DC 20036
Tel: 202-776-0544
Fax: 202-776-0545
E-Mail: ash@hematology.org

American Society of Hematology Alternative Training Pathway Grant

Purpose

The need for clinicians and clinical/translational researchers in hematology-related disciplines is strong. In recognition of the changing role of the hematologist and of current and future anticipated workforce needs, training opportunities for physicians interested in hematology-related careers must be expanded. The American Society of Hematology invites Training Program Directors and other educators to submit proposals for novel training initiatives that will augment existing training programs. The Alternative Training Pathway Grant is intended to address the needs of trainees with primary interest in various aspects of hematology and to encourage competency-based training in established and emerging areas of hematology. Additionally, the grant is intended to produce clinicians and clinician-scientists with the skills to apply the full array of technologies made available through advancing medical sciences for the management of complex hematologic problems.

Description of Need

The Alternative Training Pathway Grant is intended to foster the development and implementation of creative new curricula for trainees in clinical and clinical/translational hematology and related fields. A growing number of trainees are expressing an interest in pursuing hybrid careers (e.g., medicine/pediatrics) and/or a desire to become trained in both clinical care and laboratory medicine (e.g., transfusion medicine or directing hemostasis laboratories). The Alternative Training Pathway Grant is designed to allow training program directors to develop a curriculum that meets these new demands.

Support

Grants of up to $50,000 will be awarded to support the development and implementation of novel hematology-related training programs as an alternative to traditional training programs. The award may be expended over a one- to two-year period of time. No institutional overhead (i.e., indirect) costs will be supported by this grant.

Eligibility

Applicants must be Active Members of the American Society of Hematology (ASH) at institutions with an accredited training program(s) in adult or pediatric hematology or hematology/medical oncology, or in other hematology-related disciplines (e.g., pathology specialties) in the United States, Canada, or Mexico. Awards are limited to only one application per institution. Awardees must commit to providing progress reports and final reports as defined in the terms of the grant.

Letter of Intent

To be considered for this award, prospective applicants must submit a completed letter of intent (LOI) via e-mail no later then 5:00 p.m. EST, on Monday, February 2, 2009. The LOI must include (1) descriptive title of the proposed alternative training pathway; (2) contact information for the principal investigator; (3) names of other key personnel; (4) participating institution(s); and; (5) an abstract of the proposed alternative training pathway.

Key Dates:

Letter of Intent Due: February 2, 2009
Application Due: March 27, 2009
Peer Review: April-May 2009
Committee Review: May 2009
Award Notification Date: June 2, 2009
Funds Activated: July 1, 2009

Questions regarding this application and the ASH Alternative Training Pathway Grant should be directed to Joe Basso, Training Manager, at jbasso@hematology.org or 202-552-4910.

Federal Pharmacists Incentive Grants

Application Deadline: December 15, 2008

The APhA Foundation will award grants in the amount of $2,000 for projects to be initiated for military or civil service pharmacists working in the Army, Air Force, Coast Guard, Navy, Department of Veterans Affairs or the Public Health Service. The grants provide seed money to help pharmacists in federal sector practice settings with start-up costs to establish a new pharmaceutical care project or to use as continuing development costs to expand an already existing project, and to encourage them to share their experiences with other pharmacists within the federal sector.

The Federal Pharmacists Incentive Grants program is intended to focus pharmacists’ attention on the need to re-engineer their practices along lines that incorporate more specific patient-centered services and enhance health care delivery with the use of today’s technology. The project should concentrate on a new, innovative patient care service or expand an already existing service that is of significance to the pharmacy profession and that can be evaluated for its relevance.

The incentive grant project proposals must be in one of the following areas:

* Osteoporosis
* Oncology
* Hepatitis-C
* HIV/AIDS
* Other Infectious Diseases
* Medication Therapy Management Services

The APhA Foundation has awarded incentive grants to pharmacists in a variety of practice settings for over ten years. This is the second year for the Federal Pharmacists Incentive Grants program which is made possible with support from The Roche Foundation.

While the APhA and APhA Foundation’s headquarter building undergoes a massive renovation and expansion, the current address for the APhA Foundation is:

1100 15th Street, NW, Suite 400
Washington, DC 20005-1707
Telephone: (202) 429-7565
Email: info@aphafoundation.org

American Head and Neck Society/American Academy of Otolaryngology - Head and Neck Surgery Young Investigator Combined Award

Open to new full time academic surgeons working on contemporary basic or clinical research skills focused on neoplastic disease of the head and neck in the U.S. or Canada. Two year, non-renewable, $40,000 maximum ($20,000 per year), one available annually.

The purpose of this award is to support a collaborative AHNS/AAO-HNSF research project by fostering
the development of contemporary basic or clinical research skills focused on neoplastic disease of the
head and neck among new full-time academic surgeons. The award is intended as a preliminary step in
clinical investigator career development and is expected to facilitate the recipient’s preparation of a more
comprehensive individualized research plan suitable for submission to the National Institutes of Health or
comparable funding agency.
ELIGIBILITY
Applicants must be physicians with demonstrated potential for excellence in research and teaching and
serious commitment to an academic research career in head and neck surgery. Applicants must be
members or candidate members of the American Academy of Otolaryngology-Head and Neck Surgery
and/or the American Head and Neck Society. Priority will be given to fellows or junior faculty who have
completed residencies or fellowships within four years of the application receipt date. All candidates
must be sponsored by the Chair of his/her Division or Department and by an official representative of the
institution which would administer the Award and in whose name the application is formally submitted.
Former ASHNS/AHNS or Foundation research grant recipients are eligible to compete for the
AHNS/AAO-HNSF grant. Individuals who have already competed successfully for independent research
grant support from a private or Federal funding agency are ineligible for this Award.
CONDITIONS
Research supported by this award should be specifically directed toward the pathophysiology, diagnosis,
prevention, or treatment of head and neck neoplastic disease, and may be either basic or
clinical/transnational in approach. Proposed projects shall be designed in collaboration with a preceptor
investigator and approved by the candidate's department chairperson and institution. While not
specifically required, proposals which aim to introduce new knowledge and methodology from other
disciplines to research in head and neck disease, or which demonstrate collaborative effort with members
of other related disciplines are encouraged. Projects must be designed so as to yield useful information
within the period of award, but priority will be given to projects that are also innovative with promise to
develop into new long-range or expanded research programs capable of attracting funding from other
sources. Applications must be accompanied by a letter of support from the applicant’s Department Chair
and Preceptor verifying that the applicant will be permitted to devote an appropriate amount of time to the
conduct and timely completion of the proposed research project. Applicants must obtain letters of
support/understanding from all key personnel on the project. The grantee must submit an interim
progress report to the Foundation at the end of the first year of the award.
TERMS
1. Amount: $40,000 maximum ($20,000 per year)
2. Period: 24 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Alando J. Ballantyne Resident Research Pilot Grant

For the best grant application by a resident in the U.S. or Canada. One year, non-renewable, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease. The Alando J. Ballantyne Resident Research Pilot Grant memorializes Alando J.
Ballantyne, M.D., a giving teacher, dedicated surgeon, and a devoted husband and father.
ELIGIBILITY
This grant is open to resident in U.S. or Canadian training programs. Previous AHNS or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant. However, candidates who
have successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources. The grant application must be
accompanied by letters of support from the Chair of the candidate’s academic department and from the
principal scientific advisor or mentor. These letters are to indicate a general level of support of the
applicant, the fact that the Department will make time, space, and other resources accessible for
completion of the project, and that the applicant will have appropriate supervision/support throughout the
period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the
project.
TERMS
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Pilot Grant

Open to Medical Students, residents, PhD, and junior faculty residing in the U.S. and Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease.
ELIGIBILITY
Candidates for this award should reside in the U.S. or Canada, be medical students, residents, Ph.D.s or
faculty members at the rank of associate professor or below. Previous AHNS or AAO-HNS Foundation
research grant recipients are eligible to compete for this grant. However, candidates who have
successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s
academic department and from the principal scientific advisor or mentor. These letters are to indicate a
general level of support of the applicant, the fact that the Department will make time, space, and other
resources accessible for completion of the project, and that the applicant will have appropriate
supervision/support throughout the period of the grant. Applicants must obtain letters of
support/understanding from all key personnel on the project.
TERMS
1. Amount: $10,000 maximum
2. Period: One year, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

Request for Applications: The Terri Brodeur Breast Cancer Foundation 2009 Granting Process
BACKGROUND:

The Terri Brodeur Breast Cancer Foundation is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer cures and patient treatment options. Terri Brodeur, the Foundation’s namesake, was presented with Stage 4 Breast Cancer in June 2003. Effective treatment options did not exist to help Terri. After a two-year battle, marked by courage, grace, and dignity, at the young age of 41 years, Terri succumbed to the disease, leaving behind a beloved husband and three cherished children. The Foundation is founded on the pledge of delivering 100 percent of gross fundraising dollars to breast cancer science. The Foundation’s Grant Program seeks to augment clinical and pre-clinical fellowships in high impact, breast cancer therapeutic research areas.

AWARDS:

This award is intended to support researchers who have received their doctorate to enable them to qualify for an independent career in breast cancer research. The foundations seeks to fund broadly across all relevant disciplines and as such focus areas can include basic, preclinical and clinical research. The award period is for two years with an interim renewal to occur at one year. Stipends are $45,000 per year, with an additional $5,000 allocated for institutional overhead costs.

Foundation awards are intended to support young doctoral researchers, enabling them to more expediently develop independent careers geared toward breast cancer science. The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, the committee will seek to fund as many fellowships as is financially possible

APPLICATION PROCESS:

Prospective applicants are expected to submit a research plan, pre-approved by their prospective supervisor, to the foundation’s Scientific Advisory Committee. The research plan must be fundamentally sound and will include statements of: (a) The scientific and technical merit of the research question; (b) The design, methodology, and feasibility of the study; (c) The relevance of the proposed research plan to the applicant’s career objectives; (d) The medical and health significance of the proposed research to breast cancer prevention, control and/or treatment; and (e) The appropriateness of the research plan as a vehicle for developing necessary research skills. The applicant should also present evidence of the institutional commitment to the development of the applicant; the quality and relevance of the training environment and mentored relationship for the professional development of the applicant; the adequacy of the research facilities and training opportunities for the proposed project; and the appropriateness of the facilities and environmental resources available to the candidate. The application should not exceed 10 pages in length. However, the review committee reserves the option of asking applicants for additional supportive information. Also include a budget, letter(s) of support from appllicant's mentor, and institutional letter of support.

SOURCE OF FUNDS:

The Terri Brodeur Breast Cancer Foundation obtains its funds principally from private and corporate donations collected annually by our volunteers, and through organized fundraising events approved by the Foundation.

DEADLINES:

A preliminary application is mandatory for those applying for a 2009 fellowship grant and must be submitted by October 15, 2008. Proposals should be submitted as a hard copy as well as sent electronically to the addresses given below:

The Terri Brodeur Breast Cancer Foundation
PO Box 785
New London, CT 06320
Attn: Dr. Nicholas A. Saccomano

Saccomano@Bendres.com

Applications will be reviewed promptly by the scientific advisory committee. Depending on the grant, the committee will evaluate applications based on the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of breast cancer or to the benefit to be gained by persons with breast cancer. The evaluations of the committee are provided to the Foundation’s Board of Directors. After considering the relative merit of the applications, the amount of available funds and the Foundation’s objectives, the board will determine which grants will be funded. Applications that are not funded may be revised and resubmitted.

NOTIFICATION OF APPLICATION RECEIPT AND REVIEW:

Approximately one month after receipt of the application, the applicant will receive an email acknowledgment confirming receipt of application and an approximate date upon which the committee will communicate a decision back to the applicant.

PUBLICATIONS AND OTHER RESEARCH COMMUNICATIONS:

Publications resulting from research, or training activities supported by the American Cancer Society, must contain the following acknowledgment: "Supported by Terri Brodeur Breast Cancer Foundation”.

The Sidney Kimmel Foundation for Cancer Research utilizes an on-line application available at www. kimmel.org/cancerresearch. Problems or questions about the application process may be address to kfletche@gbmc.org.

Kimmel Scholar Award

To select the grant recipients, the Sidney Kimmel Foundation for Cancer Research has created a Medical Advisory Board consisting of distinguished cancer researchers. Each year the Kimmel Foundation expects to select up to ten grant recipients who will receive $100,000 per year for two years. Qualified applicants must hold an M.D., Ph.D. or equivalent graduate degree and must perform research in an American not-for-profit institution during the period of Kimmel Foundation support.

The Kimmel Foundation is seeking accomplished young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2005. However, physicians who have both clinical and research responsibility are eligible if appointed on or after July, 2004. These awards are designed for researchers who do not yet have their own R01 funding. Applicants will be judged on the basis of quality of prior work, research proposed and letters of support. Funding of awards will be subject to execution of binding agreements setting forth terms and conditions under which scholarships will be provided. Applicants for 2009 awards will be notified by mid-April, 2009.

The Kimmel Translational Science Award

The Foundation provides five additional awards specifically for physicians engaged in translational science. Eligibility includes those with M.D. or equivalent degrees, who have achieved the rank of Assistant Professor on or after July, 2004. Candidates must not hold R01 funding for the laboratory component of their cancer research. Applicants must demonstrate a significant personal involvement in the laboratory component of the translational project described. The translational research may involve primarily animal studies but must include reasonable application to subsequent human investigation.

Each application consists of the following:

Personal Statement (1-2 pages)

Please provide a statement about career objectives as they relate to cancer research and explain how your work satisfies the mission of The Sidney Kimmel Foundation for Cancer Research. The statement should include a description of the work environment and necessary resources available to conduct research and a statement of the approximate percent of effort to be devoted to research, teaching, patient care, administration, and other duties. Be sure to explain how your research will aid our understanding and treatment of human malignant diseases. Attach curriculum vitae.

Research (limit narrative to 3 pages)

Please describe your work in cancer research, including a brief description of pertinent supporting studies. Outline the future direction of current research and include other potential areas of interest. Explain the importance of your work to our understanding of cancer and implications for future therapies of malignant disease or cancer prevention. Graphs, figures, tables and references may be uploaded to the appendix section or included within the narrative.

Budget (1 page)

The Kimmel Scholar Award provides $100,000 per year for two years. The Kimmel Foundation will not provide additional institutional overhead but part of the grant may be budgeted toward overhead costs. The Foundation requests that institutions limit overhead to 15% or less. Please approximate the manner in which funds will be allocated among categories such as salary support, research, equipment, travel, administrative costs, etc. Also describe in detail all other current and pending funding including source, amount and duration of such support. The Foundation will not consider applicants who are already fully funded by R01 grants or who are currently the beneficiary of another similar scholar award which supports cancer research.

Personal References (1-2 pages each)

Please provide three letters of reference. The on-line application will generate a request to your references asking for a letter on your behalf. One letter must be from the Chairman of your Division or Department, and two from appropriate physicians and/or scientists who are familiar with your work. Letters may be sent under separate cover but must be received by December 31. Letters should broadly review the independence and importance of the applicant's work in the context of similar work from other laboratories. Rank the independence and quality of the work, within the reviewer's experience. Assess the overall contribution of the applicant in published papers which involved collaboration with senior investigators.

Appendix

Please supply up to three original papers (authored by applicant) from peer reviewed journals. If available, submit one or more papers or editorials from other sources which elucidate the background or importance of your work (helpful, but not required).

Cover Page (1 page)

Each application should include the standardized cover page, which will be automatically generated upon completion of the on-line application. Please print a copy of the cover page, sign and attach with the hardcopies to be mailed. The cover page should be completed with appropriate demographic information, as requested. Please provide an abstract of the current research and a brief explanatory title. An institutional official who is responsible for budget oversight must also personally sign the cover page for submission to the Foundation. Electronic signatures or copies will not be acceptable.

Completed Applications

The full on-line application should include the standardized cover page, description of research, personal statement, three letters of recommendation, budget and curriculum vitae. Please also supply a signed original and one copy of the application by mail within two days of completed on-line submission. Also include copies of appendix (samples of investigator's and relevant supporting published work). On-line applications must be completed by Wednesday, December 3, 2008 at noon EST. Letters of reference must be submitted preferably by reply email to The Foundation by December 31.

Please submit to:

Gary I. Cohen, M.D.
Cancer Center at GBMC
6569 North Charles Street, Suite 201
Baltimore, MD 21204

Friends For An Earlier Breast Cancer Test awards funding and grants for cancer research that demonstrates the potential for discovering earlier methods of breast cancer detection, such as a biological test. Through breast cancer funding research with specifically focused seed money grants, money directed from Friends is leveraged to help researchers pursue promising ideas. As a result of this preliminary work, it can be determined if research projects should be continued, ended, or altered. Our Medical Advisory Board annually selects the most worthy projects to receive funding. Without the opportunity for exploration worthy of new ideas, the disease of breast cancer can only change incrementally.

Deadline for application is December 1st.

Telephone:
Toll free: 888-792-3062
Local: 336-286-6620
Fax: 336-286-6680

Email:
Business Office: friends@earlier.org